Work

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.10.007

Authors: Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Suneet Shukla, Suresh V. Ambudkar, Dexin Kong, Zhe-Sheng Chen

Institutions: St. John's University, Tianjin Medical University, National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Natural Science Foundation of China, Tianjin Medical University, National Institutes of Health, National Cancer Institute

Awards: G4231422817, G4648929521, G9000273969

OpenAlex ID: W2896062486

FWCI: 4.547

Cites: 69

Cited by: 105

Related to: 10